×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Gold Loan
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Budget 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Pharmaceutical
Pharmaceutical
Cipla stock crashes over 3% as brokerages cut targets on Lanreotide disruption, FY27 risks
Chart of the Day: Weight loss drugs to give fillip to Indian pharma market in 2026
Cough syrup-related deaths: Pharma factory in Tamil Nadu probed after 9 children die from consuming 'Coldrif' in MP
Trump's 100% tariff on branded drugs: Exporters assessing impact on complex generics
FTAs are welcome but don’t let them undermine pharma industry and drug access
Pharma stocks rise up to 4% after better-than-expected Trump order on lower drug prices
Sun Pharma’s Q2 net profit jumps 28% on-year to Rs 3,040 crore, beats expectations
ICMR, Panacea Biotec initiate 1st ever phase-three clinical trial for dengue vaccine in India
Sun Pharma Q1 Results: Net profit jumps 40% on-year to Rs 2,836 crore, beats estimates
Cipla Q1 Results: Net profit rises to Rs 1,178 crore, beats estimate
Steady US sales to bring a healthy quarter for pharma sector
Indian pharmaceutical market registers 9.5% growth in March
Essential medicines to be slightly costlier from April 1
Why government is cracking down on junkets, gifts for doctors by pharma firms
Will a new pharmaceutical marketing code succeed where earlier attempts failed?
Sun Pharma to acquire 16.33% stake of Surgimatix for $3.05 million
JB Pharma Q2 results: Net Profit up 35% to Rs 150.5 crore
Low expectations ahead of September quarter earnings
Aurobindo Pharma’s Telangana plant classified as VAI by US FDA
Lupin Q1 results: Net profit at Rs 453.33 crore from year-ago loss, tops Street estimates
Zydus Lifescience Q1 PAT seen up 58.6% YoY to Rs 839.1 cr: Nirmal Bang
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
Sun Pharma Q1 PAT seen up 8.6% YoY to Rs 2,238.8 cr: Nirmal Bang
Natco Q1 PAT seen up 36.2% YoY to Rs 436.5 cr: Nirmal Bang
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio